tiprankstipranks
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market
2511
Hightide Therapeutics Inc
RESEARCH TOOLSreports

Hightide Therapeutics Inc (2511) Stock News & Sentiment

1 Followers
HighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results
Premium
Company Announcements
HighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results
15d ago
2511
HighTide positions HTD1801 as potential foundational therapy for CKM diseases
Premium
Company Announcements
HighTide positions HTD1801 as potential foundational therapy for CKM diseases
18d ago
2511
HighTide Therapeutics Sets March 27 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
HighTide Therapeutics Sets March 27 Board Meeting to Approve 2025 Annual Results
1M ago
2511
HighTide’s First NDA for Diabetes Drug HTD1801 Accepted by China’s NMPA
Premium
Company Announcements
HighTide’s First NDA for Diabetes Drug HTD1801 Accepted by China’s NMPA
1M ago
2511
HighTide Flags Trial Quality Issues After Completing Phase IIb MASH Study of HTD1801
Premium
Company Announcements
HighTide Flags Trial Quality Issues After Completing Phase IIb MASH Study of HTD1801
2M ago
2511
HighTide Therapeutics Names Veteran Cardiometabolic Leader Filip Surmont as Chief Medical Officer
Premium
Company Announcements
HighTide Therapeutics Names Veteran Cardiometabolic Leader Filip Surmont as Chief Medical Officer
2M ago
2511
HighTide Therapeutics Sets Up Nomination Committee to Bolster Governance
Premium
Company Announcements
HighTide Therapeutics Sets Up Nomination Committee to Bolster Governance
4M ago
2511
More HK:2511 News >

2511 News on the Web

HighTide Therapeutics Highlights HTD1801’s Potential as Foundational CKM Therapy in 2025 Results
TipRanks News
Bullish
HighTide positions HTD1801 as potential foundational therapy for CKM diseases
TipRanks News
Bullish
HighTide Therapeutics Sets March 27 Board Meeting to Approve 2025 Annual Results
TipRanks News
Neutral
HighTide’s First NDA for Diabetes Drug HTD1801 Accepted by China’s NMPA
TipRanks News
Bullish
HighTide Flags Trial Quality Issues After Completing Phase IIb MASH Study of HTD1801
TipRanks News
Bearish
HighTide Therapeutics Sets Up Nomination Committee to Bolster Governance
TipRanks News
Neutral
Hightide Therapeutics Announces New Share Placement to Fund Lead Compound Development
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2511’s Media Buzz Sentiment?
Currently, no data Available
What is HK:2511’s weekly average amount of articles?
Currently, no data Available
What is HK:2511’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
ALLOAllogene Therapeutics
STAAStaar Surgical
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week